ClinicalTrials.gg
RecruitingNCT06062797Updated Oct 2, 2023

Improving Patient Understanding in Preoperative Informed Consent Process of Trauma Patients Using a Mixed Reality Viewer

An interventional study of Mixed Reality Viewer and X-ray or CT scan in Distal Radius Fractures, Ankle Fractures and Proximal Humeral Fracture, sponsored by LMU Klinikum. Recruiting at 1 site in Germany. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2023-10-02.

Sponsored by LMU Klinikum · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Registered 5 months after the study started (first participant enrolled Apr 2023, registered Sep 2023).
  • Started Apr 2023; still recruiting 3 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This clinical trial aims to compare a Mixed Reality Viewer in the preoperative informed consent process to standard fracture visualization. The participants population are patients with an indication for surgery of a distal radius fracture, upper ankle fracture or proximal humerus fracture using plate osteosynthesis.

The main questions aim to answer are:

  • Does the use of the Mixed Reality Viewer improve patient understanding?
  • Does the use of the Mixed Reality Viewer improve patient satisfaction?
  • Does the use of the Mixed Reality Viewer reduce patient preoperative anxiety?

Participants will have their fracture presented via the Mixed Reality Viewer. Researchers will compare standard fracture imaging using X-ray or CT scans to see if there is any difference in understanding, satisfaction and anxiety.

Read the detailed description

In everyday clinical practice, patients receive a verbal explanation of their medical condition, optional treatment options, and information about the benefits, risks and complications of surgery during preoperative education. To visualize the respective fractures to the patients, they are shown using X-rays, CT scans or MRI images. However, these images are often difficult to understand without prior medical knowledge.

A better understanding of the fracture by the patients and a more comprehensible visualization of the operations can lead to better informed consent between the patients and the doctor. Consequential benefits for treatment and postoperative follow-up may follow.

The investigators hypothesis is that fracture visualization using a Mixed Reality Viewer can generate higher fracture understanding in patients. As a result of better education, this visualization method could lead to higher patient satisfaction and anxiety reduction.

Patients with an indication for surgery of a distal radius fracture, upper ankle fracture or proximal humerus fracture using plate osteosynthesis are randomized into the intervention group or the control group. Both study groups watch verbal education via a recorded video. The intervention group afterward receives a fracture visualization via mixed reality glasses. The control group receives fracture visualization via X-ray or CT scan.

In both the intervention group and the control group, the type of fracture, the extent of the fracture, the surgical method, and the benefits and risks of the surgery are explained to the patients during the visualization.

After the explanation is completed, patients are asked to complete a questionnaire regarding satisfaction and fracture understanding.

02

Conditions studied

  • Distal Radius Fractures
  • Ankle Fractures
  • Proximal Humeral Fracture

Keywords

  • Distal Radius Fracture
  • Proximal Humeral Fracture
  • Ankle Fracture
  • Mixed Reality
  • Patient Education
  • Informed Consent
  • Patient Satisfaction
03

In context

Wrist Fractures

331 studies on the registry are indexed under Wrist Fractures; 71 are open to participants now.

This study's planned enrollment of 50 is below the median of 64 across 266 interventional studies indexed under Wrist Fractures.

Browse Wrist Fractures studies →

Lead sponsor

LMU Klinikum is the lead sponsor of 53 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Indication for surgery of a distal radius fracture, upper ankle fracture, or proximal humerus fracture using plate osteosynthesis
  • Age ≥ 18 years old
  • Existing signed confirmation of participation in the study
  • Ability to understand a German interview and questionnaire

Exclusion criteria

Exclusion Criteria:

  • Epilepsy
  • Patients with mental limitations (e.g. dementia) or severe visual impairments that prevent emergency surgery
  • Age \< 18 or > 80 years old
  • Inability to understand a German interview and questionnaire
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Mixed Reality

    Fracture visualization via Mixed Reality Viewer

    Device: Mixed Reality Viewer

  • Active comparator
    X-ray or CT scan

    Fracture visualization via X-ray or CT scan

    Device: X-ray or CT scan

Interventions

  • DeviceMixed Reality Viewer

    The Mixed Reality Viewer from Brainlab (Germany) enables the visualization of the fracture via a 3D hologram. In contrast to virtual reality, where the user is in a completely virtual world, the user of the mixed reality viewer sees the 3D hologram implemented in his real environment.

  • DeviceX-ray or CT scan

    X-ray or CT scan enables the visualization of the fracture in 2D.

06

What researchers measure

Primary outcomes

  1. Patient Understanding

    A questionnaire is used to determine the patients' level of understanding via content-related questions about their specific fractures. Patients answer questions on a 6-point Likert scale, with higher scores indicating better outcome.

    Time frame: Measurement is assessed via a questionnaire immediately after the procedure.

  2. Patient Satisfaction with the educational process assessed by the 6-point Likert scale

    A questionnaire is used to determine the patient's satisfaction with the educational process. Patients answer questions on a 6-point Likert scale, with higher scores indicating better outcome.

    Time frame: Measurement is assessed via a questionnaire immediately after the procedure.

  3. Patient Preoperative Anxiety

    A questionnaire is used to determine the patient's anxiety regarding their upcoming surgical procedure. Patients answer the question on a 10-point Likert scale, with higher scores indicating worse outcome..

    Time frame: Measurement is assessed via a questionnaire immediately after the procedure.

07

Study locations

1 of 1 sites recruiting
  • Department of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), University Hospital, LMU Munich
    Munich, Bavaria 81377, Germany
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2023 (actual). Primary completion is estimated for Dec 2023, 8 months after the start.

Of 128 non-industry interventional studies with no phase under Wrist Fractures, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 8 months is below that.

Counting every sponsor, half of 129 studies reached it within 24 months; a quarter within 16 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2023
First posted
Oct 2, 2023
StartActual
Apr 18, 2023
Primary completionEst.
Dec 31, 2023
CompletionEst.
Dec 31, 2023
Last update
Oct 2, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 2, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06062797
Lead sponsor
LMU Klinikum
Responsible party
Konstantin Wehrkamp (Principal Investigator, LMU Klinikum) — Principal investigator
First posted
Oct 2, 2023
Start date
Apr 18, 2023
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Oct 2, 2023

Study contacts

Rouven Neudeck
Contact
r.neudeck@med.uni-muenchen.de
+49 (0)894400-83203
Fabian Gilbert, PD Dr. med
study director · LMU Munich

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion